Regardless of the mechanism, the list of cancers in which METCAM/MUC18 plays a tumor suppressor role has been extended from only ovarian cancer [14,29,30,31], mouse melanoma subline K1735-9 [32], and colorectal cancer [40] to include NPC type I (this study). This evidence concerns the gene MCAM and ovarian carcinoma.